(Q48131801)

8 February 2018

title

Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation (English)

1 reference

8 February 2018

1 reference

8

1 reference

8 February 2018

author name string

Haiying Cheng

1

1 reference

8 February 2018

Ligang Zhou

2

1 reference

8 February 2018

Wanling Zhu

3

1 reference

8 February 2018

Ajin Wang

4

1 reference

8 February 2018

Chuyan Tang

5

1 reference

8 February 2018

Owen Chan

6

1 reference

8 February 2018

Robert S Sherwin

7

1 reference

8 February 2018

publication date

19 June 2007

1 reference

8 February 2018

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

8 February 2018

volume

293

1 reference

8 February 2018

issue

3

1 reference

8 February 2018

page(s)

E705-12

1 reference

8 February 2018

Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Sensitivity to stress: dysregulation of CRF pathways and disease development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

CRF and CRF receptors: role in stress responsivity and other behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Diverse causes of hypoglycemia-associated autonomic failure in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Primacy of liver glucosensors in the sympathetic response to progressive hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

PVN activation is suppressed by repeated hypoglycemia but not antecedent corticosterone in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Epidermal growth factor inhibits amiloride-sensitive sodium absorption in renal collecting duct cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Body cell mass: model development and validation at the cellular level of body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

CRH deficiency impairs but does not block pituitary-adrenal responses to diverse stressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Activation of ATP-sensitive K+ channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Hypothalamic and extrahypothalamic distribution of CRF-like immunoreactive neurons in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

The distribution of corticotropin releasing factor-like immunoreactive neurons in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

A CRH1 antagonist into the amygdala of mice prevents defeat-induced defensive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Glucosensing neurons in the ventromedial hypothalamic nucleus (VMN) and hypoglycemia-associated autonomic failure (HAAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Third ventricular alloxan reversibly impairs glucose counterregulatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2007

10.1152/AJPENDO.00136.2007

21 January 2018

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018